Interventional Technologies CE-marks new stent line:
This article was originally published in Clinica
Interventional Technologies has CE-marked its LP Stent family of low-pressure coronary stents. The device features trapezoidal-shaped struts with the narrow edge of each strut facing the vessel wall. This allows the stents to penetrate and support the artery with less pressure-trauma, therefore decreasing the rate of restenosis, the San Diego, California-based company said.
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.